2014 Journal Article Olmsted syndrome with erythromelalgia caused by recessive TRPV3 mutationsDuchatelet, S., Guibbal, L., de Veer, S., Fraitag, S., Nitschké, P., Zarhrate, M., Bodemer, C. and Hovnanian, A. (2014). Olmsted syndrome with erythromelalgia caused by recessive TRPV3 mutations. British Journal of Dermatology, 171 (3), 675-678. doi: 10.1111/bjd.12951 |
2014 Journal Article Proteases and proteomics: cutting to the core of human skin pathologiesde Veer, Simon J., Furio, Laetitia, Harris, Jonathan M. and Hovnanian, Alain (2014). Proteases and proteomics: cutting to the core of human skin pathologies. Proteomics - Clinical Applications, 8 (5-6), 389-402. doi: 10.1002/prca.201300081 |
2014 Journal Article Proteases: common culprits in human skin disordersde Veer, Simon J., Furio, Laetitia, Harris, Jonathan M. and Hovnanian, Alain (2014). Proteases: common culprits in human skin disorders. Trends in Molecular Medicine, 20 (3), 166-178. doi: 10.1016/j.molmed.2013.11.005 |
2014 Journal Article A new TRPV3 missense mutation in a patient with Olmsted syndrome and erythromelalgiaDuchatelet, Sabine, Pruvost, Solenn, de Veer, Simon, Fraitag, Sylvie, Nitschké, Patrick, Bole-Feysot, Christine, Bodemer, Christine and Hovnanian, Alain (2014). A new TRPV3 missense mutation in a patient with Olmsted syndrome and erythromelalgia. JAMA Dermatology, 150 (3), 303-306. doi: 10.1001/jamadermatol.2013.8709 |
2014 Journal Article Transgenic kallikrein 5 mice reproduce major cutaneous and systemic hallmarks of Netherton syndromeFurio, Laetitia, de Veer, Simon, Jaillet, Madeleine, Briot, Anais, Robin, Aurelie, Deraison, Celine and Hovnanian, Alain (2014). Transgenic kallikrein 5 mice reproduce major cutaneous and systemic hallmarks of Netherton syndrome. The Journal of Experimental Medicine, 211 (3), 499-513. doi: 10.1084/jem.20131797 |
2013 Journal Article Mechanism-based selection of a potent kallikrein-related peptidase 7 inhibitor from a versatile library based on the sunflower trypsin inhibitor SFTI-1de Veer, Simon J., Ukolova, Svetlana S., Munro, Christopher A., Swedberg, Joakim E., Buckle, Ashley M. and Harris, Jonathan M. (2013). Mechanism-based selection of a potent kallikrein-related peptidase 7 inhibitor from a versatile library based on the sunflower trypsin inhibitor SFTI-1. Biopolymers, 100 (5), 510-518. doi: 10.1002/bip.22231 |
2012 Conference Publication Non-combinatorial library screening reveals subsite cooperativity and identifies new high-efficiency substrates for kallikrein-related peptidase 14de Veer, Simon J., Swedberg, Joakim E., Parker, Edward A. and Harris, Jonathan M. (2012). Non-combinatorial library screening reveals subsite cooperativity and identifies new high-efficiency substrates for kallikrein-related peptidase 14. *, *, *. Berlin, Germany: Walter de Gruyter. doi: 10.1515/BC-2011-250 |
2012 Journal Article Selective cleavage of human sex hormone-binding globulin by kallikrein-related peptidases and effects on androgen action in LNCaP prostate cancer cellsSanchez, Washington Y., de Veer, Simon J., Swedberg, Joakim E., Hong, Eui-Ju, Reid, Janet C., Walsh, Terry P., Hooper, John D., Hammond, Geoffrey L., Clements, Judith A. and Harris, Jonathan M. (2012). Selective cleavage of human sex hormone-binding globulin by kallikrein-related peptidases and effects on androgen action in LNCaP prostate cancer cells. Endocrinology, 153 (7), 3179-3189. doi: 10.1210/en.2012-1011 |
2012 Book Chapter Natural, engineered and synthetic inhibitors of kallikrein-related peptidasesSwedberg, Joakim E., de Veer, Simon J. and Harris, Jonathan M. (2012). Natural, engineered and synthetic inhibitors of kallikrein-related peptidases. Kallikrein-related peptidases: characterization, regulation, and interactions within the protease web. (pp. 141-160) edited by Viktor Magdolen. Berlin, Germany: De Gruyter. |
2011 Journal Article Mastering the canonical loop of serine protease inhibitors: Enhancing potency by optimising the internal hydrogen bond networkSwedberg, Joakim, de Veer, Simon J., Sit, Kei C., Reboul, Cyril F., Buckle, Ashley M. and Harris, Jonathan M. (2011). Mastering the canonical loop of serine protease inhibitors: Enhancing potency by optimising the internal hydrogen bond network. PLoS One, 6 (4) e19302, e19302.1-e19302.11. doi: 10.1371/journal.pone.0019302 |
2010 Conference Publication Natural and engineered kallikrein inhibitors: An emerging pharmacopeiaSwedberg, Joakim E., de Veer, Simon J. and Harris, Jonathan M. (2010). Natural and engineered kallikrein inhibitors: An emerging pharmacopeia. IKS 2009: 3rd International Symposium on Kallikreins and Kallikrein-Related Peptidases, Munich, Germany, 30 August-2 September 2009. Berlin, Germany: Walter de Gruyter. doi: 10.1515/BC.2010.037 |
2009 Journal Article Substrate-guided design of a potent and selective kallikrein-related peptidase inhibitor for kallikrein 4Swedberg, Joakim E., Nigon, Laura V., Reid, Janet C., de Veer, Simon J., Walpole, Carina M., Stephens, Carson R., Walsh, Terry P., Takayama, Thomas K., Hooper, John D., Clements, Judith A., Buckle, Ashley M. and Harris, Jonathan M. (2009). Substrate-guided design of a potent and selective kallikrein-related peptidase inhibitor for kallikrein 4. Chemistry and Biology, 16 (6), 633-643. doi: 10.1016/j.chembiol.2009.05.008 |